Surgical Urology

Quote






anonymous said:
Your information is inaccurate. Although codes have been created, coverage decisions are still in progress. Medicare coverage, for instance, is determined regionally by committees which only meet a handful of times each year. Commercial insurers generally mirror Medicare with respect to coding, coverage, and reimbursement policy. Long story short, they'll eventually get favorable coverage.

Regarding your narrowly defined patient target segment, it's a safe bet that you're underestimating the market for a minimally- or essentially non-invasive permanent treatment intervention that can be delivered in-office.

For Coloplasters, I'd be more concerned that the overwhelming majority of division revenue (and therefore your livelihood) relies on a product that will face coverage pressure and decreasing consumer demand. Employers trying to reduce health care costs will select plans that exclude IPP coverage and/or shift a greater portion of costs to the patient in the form of higher deductibles and co-payments. On net, implant volume might be flat or even decline year-over-year.

Those who left Coloplast were wise to jump off a sinking ship.
Click to expand...

You're on the money bro. Colo has always been a laggard/follower in the implant market. Now we're following the competition into the abyss of declining market segment.

I've made good money here for a long time but I've reached the conclusion that the time has come. Who has Amersons #?
 






anonymous said:
You're on the money bro. Colo has always been a laggard/follower in the implant market. Now we're following the competition into the abyss of declining market segment.

I've made good money here for a long time but I've reached the conclusion that the time has come. Who has Amersons #?
Click to expand...

Troll troll troll. Go back under your bridge.
 






anonymous said:
You're on the money bro. Colo has always been a laggard/follower in the implant market. Now we're following the competition into the abyss of declining market segment.

I've made good money here for a long time but I've reached the conclusion that the time has come. Who has Amersons #?
Click to expand...

I'm out too. Announcement pending (or to be swept under the rug by mgmt as usual).
 






anonymous said:
Eventually. But those who left think neo is a great opportunity because the've had success selling inflatable cock pieces to a very very very narrow space of the uro market. These people will be in for a wake up call when they realized that urolift is positioned after waiting, meds, more meds, traditional surgery and then its time to try urolift. The sweet spot of the market are not the medicare patients its the guys less than 65 and older than 50. These guys want to fuck and this is exactly to whom neotract is marketing to.

The market is everyone who gets turp, tuna, tuip, buttons, laser, holep, meds, etc. The potential is millions of patients its 90% of all men after age 80 they have BPH. The reality is a tiny fraction will want to pay thousands out of pocket for urolift, unless they are younger men who still want to bust nuts.

The colo people who left are in for a shock one that will impact their wallet or purse. The grass aint greener.
Click to expand...


As vulgar as the previous comment is, it is accurate. I left and while the urolift has decent data, the tough part is that docs dont want their patients to have to pay a copay and then more money for additional anchors it is no bueno.
 






















































anonymous said:
I just heard that Boston and Dallas MH reps are leaving for Neo. Have also heard that there might be a couple more still to come...wtf?
Click to expand...
Organizations that fail to invest in 'human capital' and the professional development of its personnel lack strategic vision. How many individuals have to leave Coloplast before executive management finally acts?
 






anonymous said:
Organizations that fail to invest in 'human capital' and the professional development of its personnel lack strategic vision. How many individuals have to leave Coloplast before executive management finally acts?
Click to expand...
The org also made the decision to extract value from the MH business in order to fund two losing bets (endo and fph). They simply viewed MH as a short term cash cow. No wonder why two (or more) MH dedicated reps would leave...
 


















anonymous said:
Organizations that fail to invest in 'human capital' and the professional development of its personnel lack strategic vision. How many individuals have to leave Coloplast before executive management finally acts?
Click to expand...

Were you under the impression that CP leadership had strategic vision?

The lack of vision comes from (IMO) the Dane-centric perspective on things. There isn't an interest in developing leaders who aren't from Denmark. Hence, the lack of human capital investment here.
 


















Top Bottom
Back
Quote